Skip to content

PROCEPT BioRobotics Corporation PRCT Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

UFP Technologies logo
UFP TechnologiesUFPT
1M
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
15M0.0%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's convertible preferred stock authorized shares?
PROCEPT BioRobotics Corporation (PRCT) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has PROCEPT BioRobotics Corporation's convertible preferred stock authorized shares changed year-over-year?
PROCEPT BioRobotics Corporation's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.